Viking Therapeutics, Inc. - stock earnings
VKTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -24.6 million USD | ? USD |
| 2023Q3 | -22.5 million USD | ? USD |
| 2023Q2 | -19.2 million USD | ? USD |
| 2023Q1 | -18.5 million USD | ? USD |
| 2022Q4 | -18.8 million USD | ? USD |
| 2022Q3 | -15.4 million USD | ? USD |
| 2022Q2 | -16.1 million USD | ? USD |
| 2022Q1 | -16.0 million USD | ? USD |
| 2021Q4 | -12.4 million USD | 10 USD |
| 2021Q3 | -13.2 million USD | 2608 USD |
| 2021Q2 | -15.4 million USD | 2737 USD |
| 2021Q1 | -14.0 million USD | 2 USD |
| 2020Q4 | -10.9 million USD | ? USD |
| 2020Q3 | -9.3 million USD | ? USD |
| 2020Q2 | -9.6 million USD | ? USD |
| 2020Q1 | -9.7 million USD | ? USD |
| 2019Q4 | -7.5 million USD | ? USD |
| 2019Q3 | -5.7 million USD | ? USD |
| 2019Q2 | -7.7 million USD | ? USD |
| 2019Q1 | -4.9 million USD | ? USD |
| 2018Q4 | -5.2 million USD | ? USD |
| 2018Q3 | -6.6 million USD | ? USD |
| 2018Q2 | -6.7 million USD | ? USD |
| 2018Q1 | -3.6 million USD | ? USD |
| 2017Q4 | -4.1 million USD | ? USD |
| 2017Q3 | -6.1 million USD | ? USD |
| 2017Q2 | -5.2 million USD | ? USD |
| 2017Q1 | -5.2 million USD | ? USD |
| 2016Q4 | -3.6 million USD | ? USD |
| 2016Q3 | -3.8 million USD | ? USD |
| 2016Q2 | -3.7 million USD | ? USD |
| 2016Q1 | -3.6 million USD | ? USD |
| 2015Q4 | -5.1 million USD | ? USD |
| 2015Q3 | -4.7 million USD | ? USD |
| 2015Q2 | -7.9 million USD | ? USD |
| 2015Q1 | -5.7 million USD | ? USD |
| 2014Q4 | 1.4 million USD | ? USD |
| 2014Q3 | -261801 USD | ? USD |
| 2014Q2 | -22.8 million USD | ? USD |
| 2014Q1 | -228941 USD | ? USD |
| 2013Q4 | ? USD | ? USD |
| 2013Q2 | -22425 USD | ? USD |
| 2013Q1 | -4583 USD | ? USD |
| 2012Q4 | -111027 USD | ? USD |
VKTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -85.9 million USD | ? USD |
| 2022 | -67.4 million USD | ? USD |
| 2021 | -54.0 million USD | 10701 USD |
| 2020 | -39.5 million USD | 10731 USD |
| 2019 | -25.8 million USD | ? USD |
| 2018 | -22.1 million USD | ? USD |
| 2017 | -20.6 million USD | ? USD |
| 2016 | -14.7 million USD | ? USD |
| 2015 | -23.4 million USD | ? USD |
| 2014 | -21.9 million USD | ? USD |
| 2013 | -146247 USD | ? USD |
VKTX
Price: $76.97
52 week price:
Earnings Per Share: -0.91 USD
P/E Ratio: -30.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -4.7 millionMarket Capitalization: 8.2 billion